×
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
OTCMKTS:ITHUF

iAnthus Capital Stock Forecast, Price & News

$0.06
+0.00 (+1.09%)
(As of 06/30/2022 02:28 PM ET)
Add
Compare
Today's Range
$0.06
$0.07
50-Day Range
$0.06
$0.13
52-Week Range
$0.04
$0.43
Volume
31,012 shs
Average Volume
137,988 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive ITHUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iAnthus Capital and its competitors with MarketBeat's FREE daily newsletter.

ITHUF Stock Forecast (MarketRank)

Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
iAnthus Capital logo

About iAnthus Capital (OTCMKTS:ITHUF)

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.

ITHUF Stock News Headlines

McCrory's Sunny Hill Nursery LLC
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ITHUF
Fax
N/A
Employees
930
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














iAnthus Capital Frequently Asked Questions

How has iAnthus Capital's stock performed in 2022?

iAnthus Capital's stock was trading at $0.0980 on January 1st, 2022. Since then, ITHUF stock has decreased by 34.0% and is now trading at $0.0647.
View the best growth stocks for 2022 here
.

Are investors shorting iAnthus Capital?

iAnthus Capital saw a increase in short interest in June. As of June 15th, there was short interest totaling 54,100 shares, an increase of 695.6% from the May 31st total of 6,800 shares. Based on an average daily volume of 188,700 shares, the short-interest ratio is currently 0.3 days.
View iAnthus Capital's Short Interest
.

Who are iAnthus Capital's key executives?

iAnthus Capital's management team includes the following people:
  • Mr. Robert R. Galvin, Interim CEO, Interim COO, Sr. VP, Chief Admin. Officer & Director (Age 61, Pay $925k)
  • Mr. Julius John Kalcevich, CFO & Corp. Sec. (Age 47, Pay $950k)
  • Mr. Randy Maslow, Co-Founder & Consultant (Age 67, Pay $975k)
  • Ms. Megan W. Kulick CFA, VP of Investor Relations
  • Mr. Andrew R. Ryan Esq., Gen. Counsel
  • Mr. Ethan F. Anderson, Sr. VP of Marketing (Age 50)
  • Dr. Richard J. Boxer, Chief Medical Officer
  • Mr. John Traylor Henderson, Sr. VP of Eastern Operations
  • Mr. Michael R. Woolston, Sr. VP of Manufacturing, Supply Chain & Quality

What is iAnthus Capital's stock symbol?

iAnthus Capital trades on the OTCMKTS under the ticker symbol "ITHUF."

How do I buy shares of iAnthus Capital?

Shares of ITHUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iAnthus Capital's stock price today?

One share of ITHUF stock can currently be purchased for approximately $0.06.

How many employees does iAnthus Capital have?

iAnthus Capital employs 930 workers across the globe.

How can I contact iAnthus Capital?

iAnthus Capital's mailing address is 505 Fifth Avenue, New York, NY 10017. The official website for iAnthus Capital is www.ianthuscapital.com. The company can be reached via phone at 646 518 9411.

This page (OTCMKTS:ITHUF) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.